Veterinary pharma company spun off from Pfizer.


Updates from The Motley Fool

Latest updates on Zoetis from Fool.com.


Stock Performance

ZTS vs. S&P 500 | 2 Year Performance
View Interactive ZTS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Zoetis.
Current Price: $50.75
Prev Close: $50.76
Open: $50.68
Bid: $49.00
Ask: $52.00
Day's Range: $50.37 - $50.90
52wk Range: $38.26 - $52.64
Volume: 2,878,680
Avg Vol 3,259,287
Market Cap: $25.27B
P/E (ttm): 39.35
EPS (ttm): $1.29
Div & Yield: $0.38 (0.7%)

Company Rating

What our community thinks about Zoetis.
CAPS Rating 4 out of 5
 
117 Outperform
5 Underperform
CAPS All Stars
 
26 Outperform
0 Underperform

How do you think Zoetis will perform against the market?



You pick for Zoetis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Juan Ramon Alaix, CEO

68% Approve

Based on 53 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Zoetis.

Veterinary pharma company spun off from Pfizer.

  • Exchange: NYSE